Shree Ganesh Remedies Ltd (BSE: 540737) is an Ankleshwar, Gujarat-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹821 Cr, it ranks #1,696 by market cap among the 6,197 Indian listed companies on FinBizNet, and #50 of 86 in Medicinal Chemicals and Botanical Products. At ₹640.00 (as of 16 Nov 2026), the share price is 14.6% below its 52-week high of ₹749.85 and 30.6% above its 52-week low of ₹490.00. The share price is up 40.1% over one year and up 4.2% over three months.
| Current Price | ₹640.00 |
|---|---|
| Market Cap | ₹821 Cr |
| BSE Code | 540737 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 46.3 |
| Return on Equity | 11.53% |
| Return on Assets | 8.08% |
| 52-Week Range | ₹490.00 – ₹749.85 |
| 1-Year Price Change | +40.1% |
| 3-Month Price Change | +4.2% |
| Beta (1Y) | 0.42 |
| Dividend Yield | 0.00% |
| Headquarters | Ankleshwar, Gujarat |
| Website | www.ganeshremedies.com |
Promoters held 62.48% of Shree Ganesh Remedies Ltd's shares as of Mar 2026, unchanged from Mar 2025. Delivery averaged 63.1% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
Shree Ganesh Remedies Limited engages in the manufacture and sale of pharmaceutical drug intermediates for active pharmaceutical ingredient (API) and fine chemicals in India and internationally. The company offers anti-arrhythmic, anti-cancer, anti-depressant, anti-diabetic, anti-diarrheal, antifungal, antihistamine, anti-inflammatory, anti-parasitic, anti-psychotic, anticholinergic, birth-control, cardiovascular, gastrointestinal, neurological disorder, ophthalmic, opioid, and veterinary API intermediates. It also provides fine and specialty chemicals, such as agro-chemicals, electronics, flavor and fragrance, life-sciences, and polymer chemicals, as well as other specialty chemicals. In addition, the company offers customized chemistry development and manufacturing; assets and infrastructure; and customized processes of pharmaceutical chemicals. It also exports its products. The company serves life sciences, flavor and fragrance, polymer industries, electronics, and agro chemicals ma
1. Bulk Drug Intermediates-This segment engages in the pharmaceutical intermediates and specialty chemical businesses.
1. Bulk Drug Intermediates-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,56,425 Cr | 39.5 | 14.72% | ₹16,199 Cr | +11.2% |
| Laurus Labs Ltd | ₹1,31,242 Cr | 145.6 | 17.74% | ₹2,206 Cr | +146.8% |
| Zydus Lifesciences Ltd | ₹1,19,651 Cr | 24.1 | 18.32% | ₹7,910 Cr | +26.0% |
| Dr.Reddys Lab | ₹1,15,464 Cr | 26.9 | 11.52% | ₹8,698 Cr | +14.5% |
| Cipla Limited | ₹1,14,712 Cr | 29.3 | 11.74% | ₹7,404 Cr | -7.6% |
| Mankind Pharma | ₹1,09,870 Cr | 57 | 12.45% | ₹4,338 Cr | +16.7% |
| Aurobindo Pharma Ltd. | ₹1,05,150 Cr | 30 | 9.93% | ₹10,263 Cr | +59.8% |
| Lupin Ltd | ₹92,087 Cr | 17.3 | 26.91% | ₹7,827 Cr | +0.4% |
| Shree Ganesh Remedies Ltd | ₹821 Cr | 46.3 | 11.53% | — | +40.1% |
Listed by market capitalisation. Ratios are shown for context only.
Shree Ganesh Remedies Ltd is trading at ₹640.00, with a market capitalisation of ₹821 Cr.
Shree Ganesh Remedies Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Shree Ganesh Remedies Ltd has a P/E of 46.3 and a return on equity of 11.53%.
Shree Ganesh Remedies Ltd is listed on the BSE under the scrip code 540737.
Shree Ganesh Remedies Ltd's share price is up 40.1% over one year and up 4.2% over three months. Its 52-week range is ₹490.00 to ₹749.85.
Promoters held 62.48% of Shree Ganesh Remedies Ltd's shares as of Mar 2026, unchanged from Mar 2025.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.